| Jana M Dahn, NP-C | |
|
325 E Main St, Anoka, MN 55303-2401 | |
| (763) 324-4620 | |
| (763) 324-4622 |
| Full Name | Jana M Dahn |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 325 E Main St, Anoka, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154504678 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 1391 (Minnesota) | Primary |
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis to standard side-hole, catheter-directed thrombolysis for the treatment of acute peripheral arterial thrombotic occlusions.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
› Verified 5 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis to standard side-hole, catheter-directed thrombolysis for the treatment of acute peripheral arterial thrombotic occlusions.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
› Verified 5 days ago
| Entity Name | Regional Physician Services Of Minnesota Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588998744 PECOS PAC ID: 3678839842 Enrollment ID: O20171106000624 |
News Archive
EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis to standard side-hole, catheter-directed thrombolysis for the treatment of acute peripheral arterial thrombotic occlusions.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jana M Dahn, NP-C 8170 33rd Ave S, Ms21110q, Minneapolis, MN 55425-4516 Ph: () - | Jana M Dahn, NP-C 325 E Main St, Anoka, MN 55303-2401 Ph: (763) 324-4620 |
News Archive
EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis to standard side-hole, catheter-directed thrombolysis for the treatment of acute peripheral arterial thrombotic occlusions.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
› Verified 5 days ago
Haron Nyakundi Manwa, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3301 7th Ave, Anoka, MN 55303 Phone: 651-431-5000 | |
Akhsa Simonovich, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3924 193rd Ln Nw, Anoka, MN 55303 Phone: 763-438-1449 | |
Jessica Kenser, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 952-883-5790 | |
Addie Noel Ketelsen, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7231 Sunwood Dr Nw, Anoka, MN 55303 Phone: 763-236-0000 | |
Mary Stephens, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-587-4200 Fax: 763-587-4205 | |
Ms. Elaine Hedlund Fitzgerald, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3301 7th Avenue North, Anoka, MN 55303 Phone: 651-431-5179 | |
Jill Maria Scott, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 630 E Main St, Anoka, MN 55303 Phone: 763-712-1903 Fax: 763-712-1917 |